Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2000 2
2004 2
2006 1
2007 1
2009 5
2010 10
2011 9
2012 17
2013 22
2014 30
2015 22
2016 24
2017 17
2018 9
2019 17
2020 21
2021 18
2022 12
2023 21
2024 15
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

248 results

Results by year

Filters applied: . Clear all
Page 1
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
Dickinson MJ, Barba P, Jäger U, Shah NN, Blaise D, Briones J, Shune L, Boissel N, Bondanza A, Mariconti L, Marchal AL, Quinn DS, Yang J, Price A, Sohoni A, Treanor LM, Orlando EJ, Mataraza J, Davis J, Lu D, Zhu X, Engels B, Moutouh-de Parseval L, Brogdon JL, Moschetta M, Flinn IW. Dickinson MJ, et al. Among authors: moschetta m. Cancer Discov. 2023 Sep 6;13(9):1982-1997. doi: 10.1158/2159-8290.CD-22-1276. Cancer Discov. 2023. PMID: 37249512 Free PMC article.
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer.
Smyth LM, Tamura K, Oliveira M, Ciruelos EM, Mayer IA, Sablin MP, Biganzoli L, Ambrose HJ, Ashton J, Barnicle A, Cashell DD, Corcoran C, de Bruin EC, Foxley A, Hauser J, Lindemann JPO, Maudsley R, McEwen R, Moschetta M, Pass M, Rowlands V, Schiavon G, Banerji U, Scaltriti M, Taylor BS, Chandarlapaty S, Baselga J, Hyman DM. Smyth LM, et al. Among authors: moschetta m. Clin Cancer Res. 2020 Aug 1;26(15):3947-3957. doi: 10.1158/1078-0432.CCR-19-3953. Epub 2020 Apr 20. Clin Cancer Res. 2020. PMID: 32312891 Free PMC article. Clinical Trial.
Macrophages in multiple myeloma.
Ribatti D, Moschetta M, Vacca A. Ribatti D, et al. Among authors: moschetta m. Immunol Lett. 2014 Oct;161(2):241-4. doi: 10.1016/j.imlet.2013.12.010. Epub 2013 Dec 24. Immunol Lett. 2014. PMID: 24370642 Review.
Budget impact analysis of introducing digital breast tomosynthesis in breast cancer screening in Italy.
Djuric O, Deandrea S, Mantellini P, Sardanelli F, Venturelli F, Montemezzi S, Vecchio R, Bucchi L, Senore C, Giordano L, Paci E, Bonifacino A, Calabrese M, Caumo F, Degrassi F, Sassoli De' Bianchi P, Battisti F, Zappa M, Pattacini P, Campari C, Nitrosi A, Di Leo G, Frigerio A, Magni V, Fornasa F, Romanucci G, Falini P, Auzzi N, Armaroli P, Giorgi Rossi P; MAITA working group; Italian Breast Cancer Screening Guidelines working group. Djuric O, et al. Radiol Med. 2024 Sep;129(9):1288-1302. doi: 10.1007/s11547-024-01850-7. Epub 2024 Aug 20. Radiol Med. 2024. PMID: 39162938
Italian guidelines for age range and test interval in breast cancer screening programmes: GRADE-ADOLOPMENT of the European guidelines.
Deandrea S, Mantellini P, Rossi PG, Vecchio R, Capobussi M, Rosselli Del Turco M, Pietribiasi F, Bucchi L, Senore C, Sardanelli F, Battisti F, Giordano L, Paci E, Parmelli E, Saguatti G, Zappa M; Italian mammography screening, diagnosis guidelines Technical/Scientific Committee, Panel, Reviewers. Deandrea S, et al. Radiol Med. 2024 Dec;129(12):1778-1789. doi: 10.1007/s11547-024-01900-0. Epub 2024 Oct 26. Radiol Med. 2024. PMID: 39460891
Nanoactuator for Neuronal Optoporation.
Pfeffer ME, DiFrancesco ML, Marchesi A, Galluzzi F, Moschetta M, Rossini A, Francia S, Franz CM, Fok Y, Valotteau C, Paternò GM, Redondo Morata L, Vacca F, Mattiello S, Magni A, Maragliano L, Beverina L, Mattioli G, Lanzani G, Baldelli P, Colombo E, Benfenati F. Pfeffer ME, et al. Among authors: moschetta m. ACS Nano. 2024 May 14;18(19):12427-12452. doi: 10.1021/acsnano.4c01672. Epub 2024 Apr 30. ACS Nano. 2024. PMID: 38687909
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer.
Planchard D, Wolf J, Solomon B, Sebastian M, Wermke M, Heist RS, Sun JM, Min Kim T, Reguart N, Sanmamed MF, Felip E, Garrido P, Santoro A, Bootle D, Couillebault XM, Gaur A, Mueller C, Poggio T, Yang J, Moschetta M, Dooms C. Planchard D, et al. Among authors: moschetta m. Lung Cancer. 2024 Nov;197:107964. doi: 10.1016/j.lungcan.2024.107964. Epub 2024 Sep 26. Lung Cancer. 2024. PMID: 39383771 Clinical Trial.
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.
de Braud F, Dooms C, Heist RS, Lebbe C, Wermke M, Gazzah A, Schadendorf D, Rutkowski P, Wolf J, Ascierto PA, Gil-Bazo I, Kato S, Wolodarski M, McKean M, Muñoz Couselo E, Sebastian M, Santoro A, Cooke V, Manganelli L, Wan K, Gaur A, Kim J, Caponigro G, Couillebault XM, Evans H, Campbell CD, Basu S, Moschetta M, Daud A. de Braud F, et al. Among authors: moschetta m. J Clin Oncol. 2023 May 10;41(14):2651-2660. doi: 10.1200/JCO.22.02018. Epub 2023 Mar 22. J Clin Oncol. 2023. PMID: 36947734 Free article. Clinical Trial.
Targeting the Bone Marrow Microenvironment.
Moschetta M, Kawano Y, Podar K. Moschetta M, et al. Cancer Treat Res. 2016;169:63-102. doi: 10.1007/978-3-319-40320-5_6. Cancer Treat Res. 2016. PMID: 27696259 Review.
Microenvironment and multiple myeloma spread.
Ribatti D, Moschetta M, Vacca A. Ribatti D, et al. Among authors: moschetta m. Thromb Res. 2014 May;133 Suppl 2:S102-6. doi: 10.1016/S0049-3848(14)50017-5. Thromb Res. 2014. PMID: 24862128 Review.
248 results